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Consistent with this model, oligoclonal T-cell expansions occur in H. pylori-associated gastritis and consecutive MALT lymphoma. 2 Other MZL-associated organisms that presumably initiate an analogous lymphomagenesis are Chlamydia psittaci, Hepatitis C virus, Borrelia burgdorferi, and C. jejuni.
1 T-cellmediated development of B-cell lymphomas with similarity to MZL also occurs regularly in a transgenic mouse model when B-cell-specific, T H 2-biased T cells provide continuous growth signals. 3 The immunoglobulin receptors of MZL cells are somatically mutated and may even undergo continuous somatic hypermutation, indicating antigen-driven affinity maturation. In contrast to the lymphoma-promoting T cells, however, the antigen receptor of the malignant B cells in MALT-eMZL appears to recognize autoantigens. 4 Beyond MZL, evidence for direct recognition of autoantigen by the malignant B cell has been obtained in chronic lymphocytic leukemia, where the antigen receptors frequently bind autoantigens in common diagnostic assays. 5 To detect a role for antigen-dependent T cells in the immunopathogenesis of indolent B-cell lymphomas in a widely applicable manner, we analyzed the T-cell receptor (TCR) repertoire of circulating CD4 þ T cells in untreated B-cell lymphoma patients in comparison to healthy age-matched control persons in a prospective study. Peripheral blood samples were obtained with informed consent from 27 previously untreated patients with indolent B-cell neoplasia and 16 age-matched ( ± 1 year) healthy individuals. Lymphoma patients comprised eight patients with follicular lymphoma, eight chronic lymphocytic leukemia patients in early disease stage, six individuals with monoclonal gammopathy of unknown significance, and five MALT-eMZL patients (Table 1) . For each entity, a separate reference group of equal size was assembled from the healthy controls. The study was approved by the institutional ethics committee.
Whole-blood samples were stained with anti-CD45-PerCP, anti-CD3-FITC and anti-CD4-APC. For absolute enumeration of CD4 þ T cells, stained cells were counted after erythrocyte lysis by flow cytometry in the presence of Trucount beads (BD Biosciences, San Diego, CA, USA). In parallel, CD4
þ T cells were enriched to 495% purity (CD4 þ T-cell isolation kit, Miltenyi, Bergisch Gladbach, Germany) as verified by flow cytometry. Purified T cells were stimulated (10 6 cells/ml) on CD3-coated plates with 3 mg/ml anti-CD28 under serum-free conditions to improve RNA yield and quality. After 40 h, that is, prior to the first cell division, total RNA was extracted (RNeasy Mini kit, Qiagen, Hilden, Germany). RNA quality was confirmed by a median RNA integrity number of 10 (range: 9.3-10; Agilent 2100 Bioanalyzer, Agilent, Santa Clara, CA, USA).
Oligo-dT-primed cDNA (cDNA Synthesis Kit, Amersham Biosciences, Piscataway, NJ, USA) was amplified by PCR for 40 cycles with 24 Vb-specific and one Cb1-Cb2 primer (Supplementary Table 1 ). PCR products were FAM-labeled by nested primer extension and analyzed by capillary electrophoresis (Avant 3100; Genescan Analysis software v3.7, Applied Biosystems, Foster City, CA, USA). CDR3 lengths were determined by subtracting the respective offset values for C, J and V length (http://imgt.cines.fr). Each individual CDR3 position was quantitated as the relative intensity of its peak area as percentage of the respective total spectratype area Letters to the Editor ( Figure 1a ). For comparisons of spectratypes between lymphoma patients and healthy controls, reference distributions were formed for every Vb family by averaging the relative quantity of each CDR3 position from the respective healthy donors. The Hamming distances of individual spectratypes were calculated as one-half of the sum of the absolute differences to this reference at each CDR3 position. Hamming distances values were compared between healthy donors and patients using the Mann-Whitney test. Benjamini-Hochberg q-values for observed differences were calculated with Expressionist v3.0 software (Genedata, Basel, Switzerland) to estimate the rate of falsepositive results. Highly significant (Po0.01) skewing of the Vb14 and Vb21 spectratypes was observed in MALT-eMZL (Figure 1 ). Less prominent TCR repertoire aberrations (Po0.05) were noted in seven additional Vb families. A Benjamini-Hochberg coefficient q of o0.2 indicated for each of these aberrations that they were unlikely to represent false-positive results. In contrast, TCR repertoire skewing was observed in follicular lymphoma , early chronic lymphocytic leukemia and monoclonal gammopathy of unknown significance only in 2-3 Vb families at a significance level of Po0.05 with a relatively high likelihood of falsepositives (q ¼ 0.3-0.5, respectively; Table 2 ).
These findings indicate that T-helper-cell repertoire changes represent a general but exclusive feature of MALT-eMZL. According to the current concept of MZL etiology, these nonrandom changes in TCR spectratypes most likely reflect a specific antigenic drive. This stimulus, however, does not simply lead to a prominent oligoclonal expansion of certain T-helper-cell clones but rather to a complex redistribution of the TCR repertoire within certain Vb TCR families (Figure 1 ). Since global peripheral CD4 þ T-cell numbers were rather reduced in MALT-eMZL and follicular lymphoma patients (Table 3) , we conclude that indolent lymphoma immunopathogenesis exerts a complex influence on the peripheral TCR repertoire with an antigen-specific component in the case of MZL and a hypothetical immunosuppressive component as indicated by lymphopenia in non-leukemic lymphoma types.
Elimination of the antigenic stimulus can lead to durable remissions of MZL. The success of this therapeutic strategy was demonstrated convincingly for gastric or conjunctival MZL by antibiotic eradication of H. pylori or doxycyclin treatment for C. psittaci, respectively. 6, 7 In contrast, empirical antibiotic treatment frequently fails in MZL when the targeted pathogens cannot be detected. 8 Since no potentially causative infectious agent was identified in two of our MZL cases, the presence of Abbreviation: n/a: not applicable.
Letters to the Editor objective TCR repertoire disturbances in the absence of known pathogens should prompt further efforts to identify hitherto unrecognized causative antigens in MZL lymphomagenesis. TCR spectratyping may also guide isolation of T-cell clones, which have undergone a relative expansion and may, therefore, serve as important research tools for the identification of novel MZL-inducing antigens. Furthermore, our results predict that MZL-associated TCR repertoire perturbations should gradually disappear after elimination of the pathogen. Consequently, TCR spectratyping should be investigated as a positive predictor for MZL-free survival after antibiotic eradication therapies. In contrast to MALT-eMZL, follicular lymphoma cells appear to acquire a pathogenetic role for the B-cell receptor through creation of novel unusual glycosylation sites within CDR regions by ongoing somatic hypermutation. 9 This process would be expected to be T-cell-independent and would be consistent with an unperturbed T-helper cell repertoire as observed in this study.
In summary, our findings support the concept of a specific systemic immune response as the cause for MZL and may guide the identification of novel disease-inducing antigens. In contrast, no peripheral T-helper-cell repertoire distortions were detected in the other indolent lymphoproliferations investigated here.
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Epigenetic aberrations are now well recognized as very frequent and also as early events in the process of malignant transformation. It is very often reported that gene-specific hypermethylation occurs in the context of global hypomethylation.
1 Accordingly, experimentally induced reduction of global methylation levels increases tumour formation in mice under certain circumstances.
2 Somewhat contradictory, in patients with myelodysplastic syndrome (MDS), the induction of hypomethylation using DNA methyltransferase inhibitors leads to very promising clinical response rates and haematological improvement. 3 Therefore, we analysed the global methylation level in a large cohort of MDS patients comprising all subgroups (n ¼ 127), to figure out the molecular mechanisms underlying this unexpected finding. Results were compared to an age-matched control group of healthy subjects (n ¼ 26; see Table 1 ). All samples were retrieved and processed following the guidelines of the local Ethics Committee.
Mononuclear cells were isolated from bone marrow aspirates and the global DNA methylation level was assessed using two completely independent methods. First, the methylation level of the highly repetitive LINE-1 sequence element, which is scattered throughout the human genome, was measured employing Pyrosequencing technology. The methylation status Significances of differences were calculated with the two-sided Mann-Whitney test.
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